Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention

Chemical Research in Toxicology

Volumn 23, Issue 6, 2010, Pages 1001-1008

  Hecht, Stephen S ^a   Yuan, Jian Min ^a   Hatsukami, Dorothy ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (N ACETYLCYSTEINYL) 2 HYDROXY 3 BUTENE; 1 HYDROXY 2 (N ACETYLCYSTEINYL) 3 BUTENE; 1 HYDROXYPYRENE; 11ALPHA HYDROXY 9,15 DIOXO 2,3,4,5 TETRANORPROSTANE 1,20 DIOIC ACID; 2 HYDROXYETHYL MERCAPTURIC ACID; 3 HYDROXYPROPYL MERCAPTURIC ACID; 3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 AMINOBIPHENYLGLOBIN; 4 HYDROXYBUT 2 YL MERCAPTURIC ACID; 9,11,15 TRIHYDROXYPROSTA 5,13 DIEN 1 OIC ACID; ACETYLCYSTEINE DERIVATIVE; BIOLOGICAL MARKER; CARBAMOYLETHYLVALINE; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CARCINOGEN; COTININE; CYANOETHYLVALINE; HEMOGLOBIN DERIVATIVE; HYDROXYETHYLVALINE; N2 ETHYLIDENE DGUO; N6 HYDROXYMETHYL DADO; NICOTINE; NICOTINIC ACETYLCHOLINE RECEPTOR A SUBUNIT 3; NICOTINIC ACETYLCHOLINE RECEPTOR A SUBUNIT 5; NICOTINIC RECEPTOR; NITROSONORNICOTINE; PROSTANOID; S PHENYL MERCAPTURIC ACID; UNCLASSIFIED DRUG; TUMOR MARKER;

CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; FEASIBILITY STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INHALATION; LAW; LUNG CANCER; METABOLIC ACTIVATION; MOLECULAR EPIDEMIOLOGY; PASSIVE SMOKING; RELIABILITY; REVIEW; SMOKELESS TOBACCO; SMOKING; TOBACCO; URINALYSIS; LEGISLATION AND JURISPRUDENCE; METABOLISM; NEOPLASMS;

NICOTIANA TABACUM;

CARCINOGENS; HUMANS; NEOPLASMS; SMOKING; TOBACCO; TUMOR MARKERS, BIOLOGICAL;

EID: 77953773582     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100056m     Document Type: Review

References (103)

1. Shafey, O., Eriksen, M. P., Ross, H., and Mackay, J. (2009) The Tobacco Atlas, 3rd ed., American Cancer Society and World Lung Foundation, Atlanta, GA.
2. Boyle, P. and Levin, P. (2004) World Cancer Report, 2008, IARC, Lyon, France.
3. Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., and Cogliano, V. (2009) A review of human carcinogens - Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish Lancet Oncol. 10, 1033-1034
4. International Agency for Research on Cancer. ((2004) Tobacco Smoke and Involuntary Smoking, in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83, pp 53 - 1187, IARC, Lyon, France.
5. President's Cancer Panel. ((2009) President's Cancer Panel 2007-2008 Annual Report, http://deainfo.nci.nih.gov/advisory/pcp/pcp.htm.
6. -(2009) State-specific secondhand smoke exposure and current cigarette smoking among adults: United States, 2008. MMWR Morb. Mortal. Wkly. Rep. 58, 1232 - 1235.
7. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C., and Hecht, S. S. (2006) Biomarkers to assess the utility of potential reduced exposure tobacco products Nicotine Tob. Res. 8, 600-622
8. U.S.Department of Health and Human Services. ((2004) The Health Consequences of Smoking: A Report of the Surgeon General, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, Rockville, MD.
9. Hukkanen, J., Jacob, P., III, and Benowitz, N. L. (2005) Metabolism and disposition kinetics of nicotine Pharmacol. Rev. 57, 79-115
10. Hecht, S. S. (2008) Progress and challenges in selected areas of tobacco carcinogenesis Chem. Res. Toxicol. 21, 160-171
11. International Agency for Research on Cancer. ((2007) Smokeless Tobacco and Tobacco-Specific Nitrosamines, in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 89, pp 421 - 583, IARC, Lyon, France.
12. Hecht, S. S. (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N -nitrosamines Chem. Res. Toxicol. 11, 559-603
13. Stepanov, I., Carmella, S. G., Briggs, A., Hertsgaard, L., Lindgren, B., Hatsukami, D. K., and Hecht, S. S. (2009) Presence of the carcinogen N' -nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products Cancer Res. 69, 8236-8240
14. Hansen, A. M., Mathiesen, L., Pedersen, M., and Knudsen, L. E. (2008) Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies: a review Int. J. Hyg. Environ. Health 211, 471-503
15. Dipple, A., Moschel, R. C., and Bigger, C. A. H. (1984) Polynuclear aromatic hydrocarbons, in Chemical Carcinogens (Searle, C. E., Ed.) 2nd ed., ACS Monograph 182, Vol. 1, pp 41 - 163, American Chemical Society, Washington, DC.
16. Carmella, S. G., Chen, M., Han, S., Briggs, A., Jensen, J., Hatsukami, D. K., and Hecht, S. S. (2009) Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers Chem. Res. Toxicol. 22, 734-741
17. U.S. Department of Health and Human Services. ((2004) Report on Carcinogens, 11th ed., p III-37 - III-39, U.S. Department of Health and Human Services, Research Triangle Park, NC.
18. International Agency for Research on Cancer. ((2008) 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 97, pp 45 - 309, IARC, Lyon, France.
19. U.S. Department of Health and Human Services. ((2004) Report on Carcinogens, 11th ed., p III-26 - III-28, U.S. Department of Health and Human Services, Research Triangle Park, NC.
20. International Agency for Research on Cancer. ((1995) Acrolein, in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 63, pp 337 - 391, IARC, Lyon, France.
21. Thompson, C. A. and Burcham, P. C. (2008) Genome-wide transcriptional responses to acrolein Chem. Res. Toxicol. 21, 2245-2256
22. Chung, F. L., Zhang, L., Ocando, J. E., and Nath, R. G. (1999) Role of 1, N 2-Propanodeoxyguanosine Adducts As Endogenous DNA Lesions in Rodents and Humans, in Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis (Singer, B. and Bartsch, H., Eds.), pp 45 - 54, International Agency for Research on Cancer, Lyon, France.
23. Feng, Z., Hu, W., Hu, Y., and Tang, M.-S. (2006) Acrolein is a major cigarette-related lung cancer agent. Preferential binding at p53 mutational hotspots and inhibition of DNA repair Proc. Natl. Acad. Sci. U.S.A. 103, 15404-15409
24. U.S. Department of Health and Human Services. ((2004) Report on Carcinogens, 11th ed., p III-42 - III-44, U.S. Department of Health and Human Services, Research Triangle Park, NC.
25. International Agency for Research on Cancer. ((1999) Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry, in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 58, pp 119 - 237, IARC, Lyon, France.
26. Morrow, J. D. (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans Arterioscler., Thromb., Vasc. Biol 25, 279-286
27. Gross, N. D., Boyle, J. O., Morrow, J. D., Williams, M. K., Moskowitz, C. S., Subbaramaiah, K., Dannenberg, A. J., and Duffield-Lillico, A. J. (2005) Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers Clin. Cancer Res. 11, 6087-6093
28. U.S. Department of Health and Human Services. ((2004) Report on Carcinogens, 11th ed., p III-6 - III-8, U.S. Department of Health and Human Services, Research Triangle Park, NC.
29. International Agency for Research on Cancer. ((1999) Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part One), in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71, pp 43 - 108, IARC, Lyon, France.
30. Klaunig, J. E. (2008) Acrylamide carcinogenicity J. Agric. Food Chem. 56, 5984-5988
31. International Agency for Research on Cancer. ((1987) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 7, pp 91 - 122, International Agency for Research on Cancer, Lyon, France.
32. International Agency for Research on Cancer. ((2006) Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 88, pp 37 - 325, IARC, Lyon, France.
33. International Agency for Research on Cancer. ((1999) Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part Two), in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71, pp 319 - 335, IARC, Lyon, France.
34. Scherer, G. (2006) Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke Exp. Toxicol. Pathol. 58, 101-124
35. Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Cogliano, V. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons Lancet. Oncol. 6, 931-932
36. Hecht, S. S. (1999) Tobacco smoke carcinogens and lung cancer J. Natl. Cancer Inst. 91, 1194-1210
37. Hecht, S. S. (2003) Tobacco carcinogens, their biomarkers, and tobacco-induced cancer Nature Rev. Cancer 3, 733-744
38. Hecht, S. S. (2010) Tobacco Smoke Carcinogens and Lung Cancer, in Chemical Carcinogenesis (Penning, T. M., Ed.), Springer, New York.
39. Rodgman, A. and Perfetti, T. (2009) The Chemical Components of Tobacco and Tobacco Smoke, pp 1483 - 1784, CRC Press, Boca Raton, FL.
40. Burns, D. M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O'Connor, R., Djordjevic, M., Dresler, C., Hainaut, P., Jarvis, M., Opperhuizen, A., and Straif, K. (2008) Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal Tob. Control 17, 132-141
41. Marian, C., O'Connor, R. J., Djordjevic, M. V., Rees, V. W., Hatsukami, D. K., and Shields, P. G. (2009) Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies Cancer Epidemiol. Biomarkers Prev. 18, 3305-3320
42. Roethig, H. J., Munjal, S., Feng, S., Liang, Q., Sarkar, M., Walk, R. A., and Mendes, P. E. (2009) Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers Nicotine Tob. Res. 11, 1216-1225
43. Stepanov, I., Upadhyaya, P., Feuer, R., Jensen, J., Hatsukami, D. K., and Hecht, S. S. (2008) Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers Cancer Epidemiol. Biomarkers Prev. 17, 1764-1773
44. Hecht, S. S., Carmella, S. G., Stepanov, I., Jensen, J., Anderson, A., and Hatsukami, D. K. (2008) Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users Cancer Epidemiol. Biomarkers Prev. 17, 732-735
45. Urban, M., Scherer, G., Kavvadias, D., Hagedorn, H. W., Feng, S., Serafin, R., Kapur, S., Muhammad, R., Jin, Y., Mendes, P., and Roethig, H. (2009) Quantitation of N′-nitrosonornicotine (NNN) in smokers urine by liquid chromatography-tandem mass spectrometry J. Anal. Toxicol. 33, 260-265
46. Boffetta, P., Clark, S., Shen, M., Gislefoss, R., Peto, R., and Andersen, A. (2006) Serum cotinine level as predictor of lung cancer risk Cancer Epidemiol. Biomarkers Prev. 15, 1184-1188
47. Church, T. R., Anderson, K. E., Caporaso, N. E., Geisser, M. S., Le, C., Zhang, Y., Benoit, A. R., Carmella, S. G., and Hecht, S. S. (2009) A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers Cancer Epidemiol. Biomarkers Prev. 18, 260-266
48. Yuan, J. M., Koh, W. P., Murphy, S. E., Fan, Y., Wang, R., Carmella, S. G., Han, S., Wickham, K., Gao, Y. T., Yu, M. C., and Hecht, S. S. (2009) Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers Cancer Res. 69, 2990-2995
49. Rundle, A. and Ahsan, H. (2008) Molecular epidemiological studies that can be nested within cohorts, in Molecular Epidemiology of Chronic Diseases (Wild, C., Vineis, P., and Garte, S., Eds.) pp 23 - 37, J.W. Wiley, New York.
50. Hatsukami, D. K., Hanson, K., Briggs, A., Parascandola, M., Genkinger, J. M., O'Connor, R., and Shields, P. G. (2009) Clinical trials methods for evaluation of potential reduced exposure products Cancer Epidemiol. Biomarkers Prev. 18, 3143-3195
51. O'Connor, R. J., Cummings, K. M., Rees, V. W., Connolly, G. N., Norton, K. J., Sweanor, D., Parascandola, M., Hatsukami, D. K., and Shields, P. G. (2009) Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example Cancer Epidemiol. Biomarkers Prev. 18, 3334-3348
52. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D., and Riedel, K. (2007) Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany Regul. Toxicol. Pharmacol. 47, 171-183
53. Hecht, S. S., Murphy, S. E., Carmella, S. G., Li, S., Jensen, J., Le, C., Joseph, A. M., and Hatsukami, D. K. (2005) Similar uptake of lung carcinogens by smokers of regular, light, and ultra-light cigarettes Cancer Epidemiol. Biomarkers Prev. 14, 693-698
54. Bernert, J. T., Jain, R. B., Pirkle, J. L., Wang, L., Miller, B. B., and Sampson, E. J. (2005) Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes Nicotine. Tob. Res. 7, 729-738
55. Benowitz, N. L., Jacob, P., III, Bernert, J. T., Wilson, M., Wang, L., Allen, F., and Dempsey, D. (2005) Carcinogen exposure during short-term switching from regular to light cigarettes Cancer Epidemiol. Biomarkers Prev. 14, 1376-1383
56. Benowitz, N. L. and Burns, D. M. (2001) Public Health Implications of Changes in Cigarette Design and Marketing, in Smoking and Tobacco Control Monograph No.13 Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine, pp 1 - 12, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD.
57. Harris, J. E., Thun, M. J., Mondul, A. M., and Calle, E. E. (2004) Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8 BMJ. 328, 72
58. U.S.Department of Health and Human Services. ((2006) The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, Washington, DC.
59. Lee, P. N. (1999) Uses and Abuses of Cotinine As a Marker of Tobacco Smoke Exposure, in Analytical Determination of Nicotine and Related Compounds and Their Metabolites (Gorrod, J. W. and Jacob, P., III, Eds.), pp 669 - 719, Elsevier, Amsterdam.
60. Jenkins, R. A., Guerin, M. R., and Tomkins, B. A. (2000) The Chemistry of Environmental Tobacco Smoke: Composition and Measurement, 2nd ed., pp 173 - 214, Lewis Publishers, Boca Raton, FL.
61. International Agency for Research on Cancer. ((1986) Tobacco Smoking, in IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, pp 37 - 375, IARC, Lyon, France.
62. -(2008) Disparities in secondhand smoke exposure: United States, 1988-1994 and 1999-2004. MMWR Morb. Mortal. Wkly. Rep. 57, 744 - 747.
63. Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D., and Hoffmann, D. (1993) A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke N. Engl. J. Med. 329, 1543-1546
64. Hecht, S. S., Carmella, S. G., Chen, M., Koch, J. F. D., Miller, A. T., Murphy, S. E., Jensen, J. A., Zimmerman, C. L., and Hatsukami, D. K. (1999) Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation Cancer Res. 59, 590-596
65. Goniewicz, M. L., Havel, C. M., Peng, M. W., Jacob, P., III, Dempsey, D., Yu, L., Zielinska-Danch, W., Koszowski, B., Czogala, J., Sobczak, A., and Benowitz, N. L. (2009) Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol Cancer Epidemiol. Biomarkers Prev. 18, 3421-3425
66. National Cancer Institute. (2009) SEER Program SEER Stat Database, www. seer. cancer. gov/faststats.
67. Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., and Hong, W. K. (2008) An expanded risk prediction model for lung cancer Cancer Prev. Res. 1, 250-254
68. Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., and Etzel, C. J. (2007) A risk model for prediction of lung cancer J. Natl. Cancer Inst. 99, 715-726
69. Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., and Begg, C. B. (2003) Variations in lung cancer risk among smokers J. Natl. Cancer Inst. 95, 470-478
70. Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., and Field, J. K. (2008) The LLP risk model: an individual risk prediction model for lung cancer Br. J. Cancer 98, 270-276
71. Carlsten, C., Sagoo, G. S., Frodsham, A. J., Burke, W., and Higgins, J. P. (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis Am. J. Epidemiol. 167, 759-774
72. Vineis, P., Veglia, F., Benhamou, S., Butkiewicz, D., Cascorbi, I., Clapper, M. L., Dolzan, V., Haugen, A., Hirvonen, A., Ingelman-Sundberg, M., Kihara, M., Kiyohara, C., Kremers, P., Le Marchand, L., Ohshima, S., Pastorelli, R., Rannug, A., Romkes, M., Schoket, B., Shields, P., Strange, R. C., Stucker, I., Sugimura, H., Garte, S., Gaspari, L., and Taioli, E. (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2,451 cases and 3,358 controls Int. J. Cancer 104, 650-657 (Pubitemid 36337268)
73. Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsater, A., Flex, A., Aben, K. K., de Vegt, F., Mulders, P. F., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., and Stefansson, K. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease Nature 452, 638-642
74. Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., Sullivan, K., Matakidou, A., Wang, Y., Mills, G., Doheny, K., Tsai, Y. Y., Chen, W. V., Shete, S., Spitz, M. R., and Houlston, R. S. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 Nat. Genet. 40, 616-622
75. Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Bencko, V., Foretova, L., Janout, V., Chen, C., Goodman, G., Field, J. K., Liloglou, T., Xinarianos, G., Cassidy, A., McLaughlin, J., Liu, G., Narod, S., Krokan, H. E., Skorpen, F., Elvestad, M. B., Hveem, K., Vatten, L., Linseisen, J., Clavel-Chapelon, F., Vineis, P., Bueno-de-Mesquita, H. B., Lund, E., Martinez, C., Bingham, S., Rasmuson, T., Hainaut, P., Riboli, E., Ahrens, W., Benhamou, S., Lagiou, P., Trichopoulos, D., Holcatova, I., Merletti, F., Kjaerheim, K., Agudo, A., Macfarlane, G., Talamini, R., Simonato, L., Lowry, R., Conway, D. I., Znaor, A., Healy, C., Zelenika, D., Boland, A., Delepine, M., Foglio, M., Lechner, D., Matsuda, F., Blanche, H., Gut, I., Heath, S., Lathrop, M., and Brennan, P. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 Nature 452, 633-637
76. Le Marchand, L., Derby, K. S., Murphy, S. E., Hecht, S. S., Hatsukami, D., Carmella, S. G., Tiirikainen, M., and Wang, H. (2008) Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine Cancer Res. 68, 9137-9140
77. Zedler, B. K., Kinser, R., Oey, J., Nelson, B., Roethig, H. J., Walk, R. A., Kuhl, P., Rustemeier, K., Schepers, G., Von Holt, K., and Tricker, A. R. (2006) Biomarkers of exposure and potential harm in adult smokers of 3-7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers Biomarkers 11, 201-220
78. Scherer, G., Urban, M., Engl, J., Hagedorn, H. W., and Riedel, K. (2006) Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure Inhal. Toxicol. 18, 821-829
79. Mendes, P., Kapur, S., Wang, J., Feng, S., and Roethig, H. (2008) A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes Regul. Toxicol. Pharmacol. 51, 295-305
80. Roethig, H. J., Zedler, B. K., Kinser, R. D., Feng, S., Nelson, B. L., and Liang, Q. (2007) Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system J. Clin. Pharmacol. 47, 518-530
81. Lowe, F. J., Gregg, E. O., and McEwan, M. (2009) Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers Clin. Chem. Lab. Med. 47, 311-320
82. Sarkar, M., Kapur, S., Frost-Pineda, K., Feng, S., Wang, J., Liang, Q., and Roethig, H. (2008) Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies Nicotine Tob. Res. 10, 1761-1772
83. Stepanov, I. and Hecht, S. S. (2005) Tobacco-specific nitrosamines and their N -glucuronides in the urine of smokers and smokeless tobacco users Cancer Epidemiol. Biomarkers Prev. 14, 885-891
84. Kavvadias, D., Scherer, G., Urban, M., Cheung, F., Errington, G., Shepperd, J., and McEwan, M. (2009) Simultaneous determination of four tobacco-specific N -nitrosamines (TSNA) in human urine J. Chromatogr., B 877, 1185-1192
85. Melikian, A. A., Djordjevic, M. V., Chen, S., Richie, J., Jr., and Stellman, S. D. (2007) Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure Cancer Epidemiol. Biomarkers Prev. 16, 1408-1415
86. Kavvadias, D., Scherer, G., Cheung, F., Errington, G., Shepperd, J., and McEwan, M. (2009) Determination of tobacco-specific N -nitrosamines in urine of smokers and non-smokers Biomarkers 14, 547-553
87. Feng, S., Roethig, H. J., Liang, Q., Kinser, R., Jin, Y., Scherer, G., Urban, M., Engl, J., and Riedel, K. (2006) Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke Biomarkers 11, 28-52
88. Suwan-ampai, P., Navas-Acien, A., Strickland, P. T., and Agnew, J. (2009) Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002 Cancer Epidemiol. Biomarkers Prev. 18, 884-893
89. Ding, Y. S., Blount, B. C., Valentin-Blasini, L., Applewhite, H. S., Xia, Y., Watson, C. H., and Ashley, D. L. (2009) Simultaneous determination of six mercapturic acid metabolites of volatile organic compounds in human urine Chem. Res. Toxicol. 22, 1018-1025
90. Scherer, G., Urban, M., Hagedorn, H. W., Feng, S., Kinser, R. D., Sarkar, M., Liang, Q., and Roethig, H. J. (2007) Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking Hum. Exp. Toxicol. 26, 37-47
91. Hoffmann, K., Becker, K., Friedrich, C., Helm, D., Krause, C., and Seifert, B. (2000) The German Environmental Survey 1990/1992 (GerES II): cadmium in blood, urine and hair of adults and children J. Expo. Anal. Environ. Epidemiol. 10, 126-135
92. Paschal, D. C., Burt, V., Caudill, S. P., Gunter, E. W., Pirkle, J. L., Sampson, E. J., Miller, D. T., and Jackson, R. J. (2000) Exposure of the U.S. population aged 6 years and older to cadmium: 1988- 1994 Arch. Environ. Contam. Toxicol. 38, 377-383
93. Batariova, A., Spevackova, V., Benes, B., Cejchanova, M., Smid, J., and Cerna, M. (2006) Blood and urine levels of Pb, Cd and Hg in the general population of the Czech Republic and proposed reference values Int. J. Hyg. Environ. Health 209, 359-366
94. McElroy, J. A., Shafer, M. M., Trentham-Dietz, A., Hampton, J. M., and Newcomb, P. A. (2007) Urinary cadmium levels and tobacco smoke exposure in women age 20-69 years in the United States J. Toxicol. Environ. Health A 70, 1779-1782
95. Reilly, M., Delanty, N., Lawson, J. A., and Fitzgerald, G. A. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers Circulation 94, 19-25
96. Pilz, H., Oguogho, A., Chehne, F., Lupattelli, G., Palumbo, B., and Sinzinger, H. (2000) Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane) Thromb. Res. 99, 209-221
97. Yan, W., Byrd, G. D., and Ogden, M. W. (2007) Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS J. Lipid Res. 48, 1607-1617
98. Duffield-Lillico, A. J., Boyle, J. O., Zhou, X. K., Ghosh, A., Butala, G. S., Subbaramaiah, K., Newman, R. A., Morrow, J. D., Milne, G. L., and Dannenberg, A. J. (2009) Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway Cancer Prev. Res. 2, 322-329
99. Scherer, G. (2005) Biomonitoring of inhaled complex mixtures - ambient air, diesel exhaust and cigarette smoke Exp. Toxicol. Pathol. 57 (Suppl. 1) 75-110
100. Wang, M., Cheng, G., Balbo, S., Carmella, S. G., Villalta, P. W., and Hecht, S. S. (2009) Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and non-smokers Cancer Res. 69, 7170-7174
101. Chen, L., Wang, M., Villalta, P. W., Luo, X., Feuer, R., Jensen, J., Hatsukami, D. K., and Hecht, S. S. (2007) Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation Chem. Res. Toxicol. 20, 108-113
102. Scherer, G. and Richter, E. (1997) Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal Hum. Exp. Toxicol. 16, 449-459
103. Hecht, S. S. (2003) Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke Tob. Control 13 (Suppl. 1) i48-i56